Beruflich Dokumente
Kultur Dokumente
Abstract
A rapid, sensitive method for the routine analysis of benzodiazepines in urine and whole blood was developed using a simple
dilute-and-shoot methodology. Partial validation experiments were conducted using fortified urine and blood samples. Linearity
was evaluated from 0.1 ng/mL to 1,000 ng/mL. Detection limits ranged from 0.1 ng/mL to 5 ng/mL and quantification limits ranged
from 0.5 ng/mL to 10 ng/mL. This method, which uses an Ultra Biphenyl LC column and an API 4000 MS/MS detector, provides a
fast 4.5 minute analysis which allows efficient monitoring of a broad range of benzodiazepines at therapeutic levels.
Introduction
Benzodiazepines are widely used to treat anxiety and sleep disorders such as restless leg syndrome. These drugs are often prescribed
in conjunction with pain management medications, due to their ability to relieve the pain caused by stress. Because of their tranquilizing qualities and relative availability, illicit use of benzodiazepines has become more common, and their analysis is now a
routine procedure in both clinical and forensic laboratories. While benzodiazepines can be analyzed by either GC/MS or LC/MS/
MS, GC/MS methods are more time-consuming and labor-intensive, as sample preparation and derivatization are required. LC/
MS/MS methods are often a better choice when higher sample throughput is desired.
The procedure and conditions presented here result in a fast dilute-and-shoot LC/MS/MS chromatographic method for therapeutic
levels of a comprehensive list of benzodiazepines in urine and whole blood. While other methods that have been developed for LC/
MS/MS range from 10 to 23 minutes, the analysis shown here is complete in 4.5 minutes, allowing more samples to be run per shift.
Experimental
Various frequently analyzed benzodiazepines were included in this chromatographic method. The compounds analyzed included
clonazepam, diazepam, lorazepam, flunitrazepam, triazolam, and their 7-amino, desmethyl, and desalkyl metabolites.
For urine samples, the urine was hydrolyzed prior to fortification by adding 1 mL of a beta-glucuronidase solution from keyhole
limpet (Sigma-Aldrich cat.# G8132) to 1 mL of urine and incubating the mixture at 60 C for 3 hours. The beta-glucuronidase solution was prepared at 5,000 Fishman units/mL in 100 mM ammonium acetate buffer (pH = 5.0). Compounds were spiked directly
into the enzymatically-hydrolyzed urine at 11 levels (0.1, 0.5, 1, 5, 10, 25, 50, 100, 200, 500, and 1,000 ng/mL). Then, each sample
was diluted 20:1 in mobile phase containing 30 ng/mL of internal standard (5 L sample + 95 L mobile phase). After dilution,
samples were centrifuged for 10 minutes at 3,000 g to remove any solids remaining in the sample, and the supernatant was removed
for analysis.
www.restek.com
For blood samples, whole blood was collected offsite and diluted 1:1 with acetonitrile in order to precipitate proteins. After precipitation, the sample was centrifuged for 10 minutes at 3,000 g. Benzodiazepines were spiked into the precipitated whole blood at the
same levels specified for urine. Then the fortified samples were diluted 10:1 in mobile phase containing 30 ng/mL internal standard
(100 L sample + 900 L mobile phase) to yield an overall 20-fold dilution. Samples were then centrifuged for 10 minutes at 3,000
g, and the supernatant was removed for analysis.
All samples were analyzed in triplicate using a Shimadzu UFLCXR HPLC coupled with an AB SCIEX API 4000 MS/MS operating
in positive electrospray mode. A 50 mm x 2.1 mm ID x 5 m Ultra Biphenyl column (cat.# 9109552) was chosen for analysis as it
provides good chromatographic retention of both polar and nonpolar compounds, including the 7-amino metabolites and more
nonpolar compounds such as diazepam. Additionally, the short column length allows for a fast analysis.
Precision and accuracy were assessed by comparing back-calculated benzodiazepine concentrations in the calibration solutions
with the prepared concentrations. Back-calculated concentrations were determined using a 1/x weighted quadratic calibration
curve for each compound.
www.restek.com
LC_CF0525
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Peaks
RT (min.)
7-Aminoclonazepam
0.59
7-Aminoflunit azepam
0.77
Bromazepam
1.10
N-Desmethylflunit azepam
1.71
Nitrazepam
1.69
Lorazepam
1.71
2-Hydroxyethylflu azepam
1.79
Nordiazepam
1.78
Estazolam
1.88
Desalkylflu azepam
1.90
Clonazepam
1.92
Alprazolam
1.99
Midazolam
1.26
Triazolam
2.06
Temazepam
2.13
Flurazepam
1.34
Flunitrazepam
2.24
Clobazam
2.26
Diazepam-D5 (IS)
2.42
Diazepam
2.45
MRM1
286.0/250.3
284.2/135.2
315.9/182.0
300.0/254.1
282.1/236.1
321.0/302.9
333.1/246.1
271.0/140.0
294.9/267.1
289.0/140.0
315.9/270.2
309.4/281.1
326.1/291.2
343.1/315.0
301.2/283.1
388.1/315.1
314.4/211.0
301.1/259.1
290.0/154.1
284.8/193.1
MRM2
286.0/222.2
284.2/240.2
315.9/209.1
300.0/225.2
282.1/207.2
321.0/275.1
333.1/166.0
271.0/208.0
294.9/241.0
289.0/165.1
315.9/214.1
309.4/205.0
326.1/244.2
343.1/308.2
301.2/255.1
388.1/288.2
314.4/239.1
301.1/224.0
284.8/222.2
Column
Ultra Biphenyl (cat.# 9109552)
Dimensions:
50 mm x 2.1 mm ID
Particle Size:
5 m
Pore Size:
100
Temp.:
40 C
Sample
Diluent:
Starting mobile phase + 30 ng/mL IS
Conc.:
100 ng/mL sample was diluted 20x prior to injection
Inj. Vol.:
30 L
Mobile Phase
A: Water + 2 mM ammonium formate + 0.2% formic acid
B: Acetonitrile + 10% water + 2 mM ammonium formate + 0.2% formic acid
Time (min.) Flow (mL/min.) %A
%B
0
0.6
70
30
3.00
0.6
40
60
3.1
0.6
5
95
3.5
0.6
5
95
3.6
0.6
70
30
4.5
stop
Detector
AB SCIEX API 4000 MS/MS
Model #:
API 4000
Ion Source:
TurboIonSpray
Ion Mode:
ESI+
Ion Spray Voltage: 2 kV
Curtain Gas:
40 psi (275.8 kPa)
Gas 1:
40 psi (275.8 kPa)
Gas 2:
40 psi (275.8 kPa)
Source Temp.:
600 C
Instrument
Applied Biosystems/MDS Sciex LC/MS/MS System
Notes
MS/MS instrument was operated in scheduled MRM mode.
MRM3
286.0/121.0
284.2/226.1
315.9/260.9
300.0/198.0
282.1/180.0
321.0/229.1
333.1/109.1
271.0/225.9
294.9/138.0
289.0/226.0
315.9/207.1
309.4/274.1
326.1/209.0
343.1/239.2
301.2/228.1
388.1/317.1
314.4/268.1
301.1/181.1
284.8/257.1
www.restek.com
Linearity
(R^2)
0.9991
0.9991
0.999
0.9982
0.9977
0.9993
0.9982
0.999
0.9993
0.999
0.9992
0.9995
LOD
(ng/mL)
0.1
0.5
5
1
5
1
5
0.5
1
1
1
5
Precision
(RSD)
3.0 - 14.6
1.4 - 15.3
2.7 - 7.7
2.0 - 10.6
3.3 - 27.3
1.4 - 19.9
3.5 - 16.5
1.4 - 22.5
1.5 - 8.8
1.6 - 12.9
1.1 - 8.7
1.2 - 18.1
Accuracy (%)
92.3 - 113.0
90.2 - 128.7
91.3 - 117.0
87.9 - 126.7
87.4 - 117.2
90.7 - 107.9
96.5 - 126.0
89.9 - 126.7
92.3 - 116.3
91.2 - 124.0
90.5 - 174.0
87.8 - 120.8
Quant.
MRM
388.1/315.1
343.1/308.2
284.2/135.2
284.2/135.2
300.0/198.0
333.1/246.1
289.0/165.1
326.1/209.0
294.9/267.1
301.1/259.1
314.4/239.1
282.1/236.1
Qual. 1
MRM
388.1/288.2
343.1/315.0
284.2/240.2
284.2/240.2
300.0/254.1
333.1/166.0
289.0/140.1
326.1/291.2
294.9/241.0
301.1/224.0
314.4/211.0
282.1/207.2
Ion Ratio 1
(Quant./Qual.)
12
0.9
6.5
0.3
0.3
1.7
0.3
0.3
6.9
3.8
3.7
3.3
Qual. 2
MRM
388.1/317.1
NA*
284.2/226.1
284.2/226.1
300.0/225.2
333.1/109.1
289.0/226.0
326.1/244.2
294.9/138.0
NA
314.4/268.1
282.1/180.0
Ion Ratio 2
(Quant./Qual.)
4
NA
4.2
0.5
1
0.5
0.5
0.9
9.6
NA
0.3
2.8
* In cases where ion ratios for an MRM showed unacceptable (>25%) variability, the transition was not used.
www.restek.com
LC_CF0522
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Peaks
7-Aminoclonazepam
7-Aminoflunit azepam
Bromazepam
N-Desmethylflunit azepam
Nitrazepam
Lorazepam
2-Hydroxyethylflu azepam
Nordiazepam
Estazolam
Desalkylflu azepam
Clonazepam
Alprazolam
Midazolam
Triazolam
Temazepam
Flurazepam
Flunitrazepam
Clobazam
Diazepam-D5 (IS)
Diazepam
RT (min.)
0.57
0.74
1.07
1.70
1.68
1.70
1.78
1.76
1.86
1.90
1.91
1.98
1.22
2.05
2.12
1.30
2.23
2.26
2.40
2.44
MRM1
286.0/250.3
284.2/135.2
315.9/182.0
300.0/254.1
282.1/236.1
321.0/302.9
333.1/246.1
271.0/140.0
294.9/267.1
289.0/140.0
315.9/270.2
309.4/281.1
326.1/291.2
343.1/315.0
301.2/283.1
388.1/315.1
314.4/211.0
301.1/259.1
290.0/154.1
284.8/193.1
MRM2
286.0/222.2
284.2/240.2
315.9/209.1
300.0/225.2
282.1/207.2
321.0/275.1
333.1/166.0
271.0/208.0
294.9/241.0
289.0/165.1
315.9/214.1
309.4/205.0
326.1/244.2
343.1/308.2
301.2/255.1
388.1/288.2
314.4/239.1
301.1/224.0
284.8/222.2
Column
Ultra Biphenyl (cat.# 9109552)
Dimensions:
50 mm x 2.1 mm ID
Particle Size:
5 m
Pore Size:
100
Temp.:
40 C
Sample
Diluent:
Starting mobile phase + 30 ng/mL IS
Conc.:
25 ng/mL sample was diluted 20x prior to injecton
Inj. Vol.:
30 L
Mobile Phase
A: Water + 2 mM ammonium formate + 0.2% formic acid
B: Acetonitrile + 10% water + 2 mM ammonium formate + 0.2% formic acid
Time (min.) Flow (mL/min.) %A %B
0 0.6
70
30
3.00
0.6
40 60
3.1
0.6
5 95
3.5
0.6
5 95
3.6
0.6
70 30
4.5
stop
Detector
AB SCIEX API 4000 MS/MS
Model #:
API 4000
Ion Source:
TurboIonSpray
Ion Mode:
ESI+
Ion Spray Voltage: 2 kV
Curtain Gas:
40 psi (275.8 kPa)
Gas 1:
40 psi (275.8 kPa)
Gas 2:
40 psi (275.8 kPa)
Source Temp.:
600 C
Mode:
MRM
Instrument
Applied Biosystems/MDS Sciex LC/MS/MS System
Notes
MS/MS instrument was operated in scheduled MRM mode.
MRM3
286.0/121.0
284.2/226.1
315.9/260.9
300.0/198.0
282.1/180.0
321.0/229.1
333.1/109.1
271.0/225.9
294.9/138.0
289.0/226.0
315.9/207.1
309.4/274.1
326.1/209.0
343.1/239.2
301.2/228.1
388.1/317.1
314.4/268.1
301.1/181.1
284.8/257.1
www.restek.com
Linearity
(R^2)
0.9994
0.9994
0.9996
0.9996
0.9996
0.9996
0.9992
0.9993
0.9993
0.9992
0.9992
0.9992
0.9994
0.9993
0.9994
0.9997
0.9995
0.9994
0.9993
LOD
(ng/mL)
0.1
0.5
0.5
0.5
1
1
1
5
0.5
1
1
1
5
0.5
1
1
1
0.5
1
Precision
(RSD)
0.8 - 20.1
1.0 - 15.2
1.0 - 5.1
0.8 - 12.2
0.5 - 29.7
1.4 - 10.2
0.7 - 36.7
1.6 - 10.7
1.2 - 14.6
1.0 - 6.3
0.5 - 3.9
1.0 - 8.2
0.6 - 13.2
0.2 - 8.6
0.4 - 14.9
0.3 - 19.7
1.0 - 14.6
0.9 - 11.0
0.9 - 12.2
Accuracy (%)
91.5-118.3
92.4-109.5
94.0 - 115.3
93.4 - 110.0
80.8 - 107.0
90.4 - 116.0
91.9 - 110.7
88.5 - 116.3
90.4 - 114.4
90.2 - 113.3
92.1 - 115.7
92.0 - 119.7
93.0 - 107.6
89.9 - 119.3
91.5 - 114.2
90.9 - 115.0
92.8 - 112.1
92.2 - 107.6
93.3 - 106.3
Quant.
MRM
388.1/315.1
343.1/308.2
286.0/222.2
284.2/135.2
284.2/135.2
300.0/198.0
333.1/246.1
289.0/165.1
326.1/209.0
294.9/267.1
301.1/259.1
309.4/281.1
315.9/270.2
284.8/193.1
314.4/239.1
321.0/302.9
282.1/236.1
301.2/255.1
371.0/140.0
Qual. 1
MRM
388.1/288.2
343.1/315.0
286.0/250.3
284.2/240.2
284.2/240.2
300.0/254.1
333.1/166.0
289.0/140.1
326.1/291.2
294.9/241.0
301.1/224.0
309.4/205.0
315.9/214.1
284.8/222.2
314.4/211.0
321.0/275.1
282.1/207.2
301.2/283.1
271.0/208.0
Ion Ratio 1
(Quant./Qual.)
11.2
1.1
1.7
6.5
1.4
0.25
1.6
0.25
0.2
6.9
4
2.1
3.4
1.3
3.6
0.6
3.4
2.5
2.5
Qual. 2
MRM
388.1/317.1
343.1/239.2
286.0/121.0
284.2/226.1
284.2/226.1
300.0/225.2
333.1/109.1
289.0/226.0
326.1/244.2
294.9/138.0
301.1/181.1
309.4/274.1
NA*
284.8/257.1
314.4/268.1
321.0/229.1
282.1/180.0
301.2/228.1
271.0/225.9
Ion Ratio 2
(Quant./Qual.)
3.8
4.5
1.3
4.5
3.4
1.05
0.5
0.5
0.8
9.9
40
4.6
NA*
1.3
0.3
1.9
2.7
20
5.3
* In cases where ion ratios for an MRM showed unacceptable (>25%) variability, the transition was not used.
Conclusions
The chromatographic method presented here allows for fast analysis of a comprehensive list of benzodiazepines at or below therapeutic levels by LC/MS/MS in both urine and whole blood samples. The total run time for this method is only 4.5 minutes using a
5 m Ultra Biphenyl HPLC column. The fast analysis time and simple dilute-and-shoot approach used here present an opportunity
for labs to increase sample throughput by replacing more time-consuming methods.
Acknowledgements
Restek would like to acknowledge Mike Coyer and Northern Tier Research for their contributions to this study.
U.S. 110 Benner Circle Bellefonte, PA 16823 1-814-353-1300 1-800-356-1688 fax: 1-814-353-1309 www.restek.com
China phone: +86-10-5629-6620 fax: +86-10-5814-3980 cn.restek.com
France phone: +33 (0)1 60 78 32 10 fax: +33 (0)1 60 78 70 90 www.restek.fr
Germany phone: +49 (0)6172 2797 0 fax: +49 (0)6172 2797 77 www.restekgmbh.de
Italy phone: +39-02-7610037 fax: +39-02-70100100 www.superchrom.it
Japan phone: +81 (3)6459 0025 fax: +81 (3)6459 0025 e-mail: restekjapan@restek.com
UK phone: +44 (0)1494 563377 fax: +44 (0)1494 564990 www.thamesrestek.co.uk